According to the SEC Form 4 filings, Hopkinson Craig C., being in a position of
No biography is available at this moment.
Buys | $0 | 0 | 0 |
Sells | $3,383,444 | 12 | 100 |
| 2026-09-01 | Sale | Alkermes plc ALKS | EVP R&D, Chief Medical Officer | 9,000 0.0053% | $46.99 | $422,874 | -7.72% | |
| 2026-08-03 | Sale | Alkermes plc ALKS | EVP R&D, Chief Medical Officer | 9,000 0.0053% | $48.58 | $437,220 | -8.34% | |
| 2026-07-01 | Sale | Alkermes plc ALKS | EVP R&D, Chief Medical Officer | 9,000 0.0053% | $51.51 | $463,621 | -9.15% | |
| 2026-06-01 | Sale | Alkermes plc ALKS | EVP R&D, Chief Medical Officer | 9,000 0.0053% | $41.67 | $375,044 | +9.07% | |
| 2026-05-01 | Sale | Alkermes plc ALKS | EVP R&D, Chief Medical Officer | 9,000 0.0054% | $33.40 | $300,560 | +35.87% | |
| 2026-04-01 | Sale | Alkermes plc ALKS | EVP R&D, Chief Medical Officer | 9,000 0.0055% | $35.51 | $319,604 | +26.33% | |
| 2026-03-02 | Sale | Alkermes plc ALKS | EVP R&D, Chief Medical Officer | 9,000 0.0054% | $29.72 | $267,485 | +42.05% | |
| 2026-02-02 | Sale | Alkermes plc ALKS | EVP R&D, Chief Medical Officer | 9,000 0.0053% | $33.93 | $305,385 | +18.84% | |
| 2026-01-08 | Sale | Alkermes plc ALKS | EVP R&D, Chief Medical Officer | 5,000 0.0031% | $30.00 | $150,005 | +36.93% | |
| 2026-01-02 | Sale | Alkermes plc ALKS | EVP R&D, Chief Medical Officer | 4,000 0.0024% | $28.00 | $112,000 | +42.27% | |
| 2025-12-03 | Sale | Alkermes plc ALKS | EVP R&D, Chief Medical Officer | 3,748 0.0023% | $30.00 | $112,447 | +27.95% | |
| 2025-12-01 | Sale | Alkermes plc ALKS | EVP R&D, Chief Medical Officer | 4,000 0.0025% | $29.30 | $117,200 | +29.46% | |
| 2025-11-03 | Sale | Alkermes plc ALKS | EVP R&D, Chief Medical Officer | 9,000 0.0054% | $30.38 | $273,442 | +17.2% | |
| 2025-10-15 | Sale | Alkermes plc ALKS | EVP R&D, Chief Medical Officer | 9,000 0.0053% | $31.53 | $283,776 | +7.14% | |
| 2025-02-13 | Sale | Alkermes plc ALKS | EVP R&D, Chief Medical Officer | 144,419 0.0947% | $35.53 | $5.13M | -17.36% | |
| 2025-02-12 | Sale | Alkermes plc ALKS | EVP R&D, Chief Medical Officer | 204,921 0.1299% | $32.78 | $6.72M | -11.19% | |
| 2025-01-30 | Sale | Alkermes plc ALKS | EVP R&D, Chief Medical Officer | 100,918 0.0633% | $32.05 | $3.23M | -6.77% | |
| 2024-12-09 | Sale | Alkermes plc ALKS | EVP R&D, Chief Medical Officer | 61,151 0.0384% | $32.07 | $1.96M | -4.5% | |
| 2024-12-05 | Sale | Alkermes plc ALKS | EVP R&D, Chief Medical Officer | 9,221 0.0058% | $31.50 | $290,462 | -3.96% | |
| 2024-12-04 | Sale | Alkermes plc ALKS | EVP R&D, Chief Medical Officer | 14,349 0.0088% | $30.77 | $441,550 | -3.49% |